QuEChERS结合超高效液相色谱-串联质谱法检验腐败血中4-甲基甲卡西酮和甲卡西酮

建立了腐败血中4-甲基甲卡西酮和甲卡西酮的超高效液相色谱-三重四级杆串联质谱(UPLC-MS/MS)检测方法。腐败血样品经乙腈水混合溶液(乙腈:水=4:1,V/V)提取,无水MgSO_4脱水和C_(18)吸附剂净化。选用Waters BEH C_(18)色谱柱分离,0.1%甲酸-水(5 mmol/L乙酸铵)和乙腈作为流动相进行梯度洗脱,电喷雾电离,正离子(ESI~+)模式扫描,多反应监测(MRM)模式检测。4-甲基甲卡西酮和甲卡西酮在0.5～100 ng/mL范围内线性关系良好(R~2≧0.9993),检出限(S/N=3)分别为0.01 ng/mL(4-甲基甲卡西酮)和0.03 ng/mL(甲卡西酮),定量限(S/N=10)分别为0.1 ng/mL(4-甲基甲卡西酮)和0.5 ng/mL(甲卡西酮)。     

液相色谱-四级杆飞行时间质谱法检验血液中的3-氯甲卡西酮

本研究建立了液相色谱-四级杆飞行时间质谱(LC-QTOF-MS)检验血样中3-氯甲卡西酮(3-CMC)的方法。血液经1:2体积的乙腈沉淀蛋白后,采用Agilent?ZORBAX Eclipse Plus C18色谱柱(3.0 mm×150 mm,1.8μm)分离,0.1%(v/v)甲酸-水(5mol·L~(-1)乙酸铵)和乙腈作为流动相梯度洗脱,电喷雾双喷离子源电离正离子模式(Dual AJS ESI+)扫描。3-氯甲卡西酮在5～500ng·mL~(-1)范围内线性关系良好,检出限和定量限分别为2ng·mL~(-1)和5ng·mL~(-1),回收率在103.6%～113.7%之间,日内精密度小于8.1%,日间精密度小于11.8%。本方法可以对血液中的3-氯甲卡西酮进行定性定量检测,能够满足实际检案的要求。     

甲卡西酮的LC-MS/MS定性定量分析方法

建立了LC-MS/MS法定性定量分析甲卡西酮。采用三重串联四极杆液质联用仪(LC/QQQ),AgilentZorbax Eclipse Plus C18色谱柱(100 mm×2.1 mm,1.8μm),流动相为0.1%甲酸-乙腈,梯度洗脱,流速为0.3mL/min。质谱应用ESI源、正离子模式、多反应监测(MRM)方式。在0.1～10 000 ng/mL质量浓度范围内线性关系良好,r2=0.999 8,日内与日间保留时间和峰面积的相对标准偏差不大于5.28%,检出限为0.04 ng/mL,回收率为95.6%～100.7%。该方法适用于甲卡西酮的定性、定量分析。     

超高效液相色谱-三重四级杆串联质谱法同时测定血样中7种常见毒品

建立超高效液相色谱-三重四级杆串联质谱(UPLC-MS/MS)同时检测血样中甲卡西酮、右美托咪啶、甲苯噻嗪、氯胺酮、哌替啶、氟哌啶醇和丁丙诺啡7种常见毒品的方法。血样经Waters Oasis MCX固相萃取柱净化后,采用ACQUITY UPLCHSS C18色谱柱(150 mm×2. 1 mm,1. 8μm)分离,流动相为乙腈-水/甲酸/甲酸铵,梯度洗脱,电喷雾电离正离子模式(ESI+),多反应监测方式(MRM)检测。7种目标物在1~200ng·mL~(-1)范围内的线性关系良好,检出限和定量限分别为0. 05~0. 1 ng·mL~(-1)和0. 2~0. 5 ng·mL~(-1),回收率在83. 2%~115. 4%之间,相对标准偏差小于7. 9%。本文方法可以同时对血样中7种常见毒品进行检测,能够满足实际检案的要求。     

中空纤维膜液相微萃取-气相色谱/质谱法检测尿液中的苯丙胺类兴奋剂

建立了尿液中痕量苯丙胺类毒品的中空纤维膜液相微萃取-气相色谱/质谱检测方法。采用中空纤维膜液相微萃取技术萃取尿液中4种苯丙胺类毒品,研究萃取剂类型、体积、溶液pH、萃取时间和温度等对萃取效果的影响。尿液中4种苯丙胺类毒品的最佳萃取条件为:样品溶液pH 13,甲苯为萃取剂,搅拌速度500 r/min,30℃条件下萃取15 min;此条件下苯丙胺(AM)、甲基苯丙胺(MAM)、3,4-亚甲二氧基苯丙胺(MDA)、3,4-亚甲二氧基甲基苯丙胺(MDMA)的检出限(S/N=3)分别为1.0,0.75,1.0,0.64 ng/mL,相对标准偏差分别为6.62%,3.98%,4.57%,2.35%,富集倍数分别为155,170,132,218倍。本方法可用于尿液中痕量苯丙胺类毒品的分析测定。     

超高效液相色谱-串联质谱法快速测定蔬菜中4种异噻唑啉酮类化合物的含量

提出了超高效液相色谱-串联质谱法(UHPLC-MS/MS)快速测定蔬菜中5-氯-2-甲基-4-异噻唑啉-3-酮(CMIT)、2-甲基-4-异噻唑啉-3-酮(MIT)、1,2-苯并异噻唑啉-3-酮(BIT)、2-正辛基-4-异噻唑啉-3-酮(OIT)等4种异噻唑啉酮类化合物含量的方法。取10.0 g已匀浆的蔬菜样品,用10 mL乙腈超声提取30 min,离心,残渣重复提取一次,合并提取液,加入5 g氯化钠,振荡、静置后,于40℃氮吹至近干,用2 mL 10%(体积分数,下同)甲醇溶液溶解残渣。所得溶液过已活化的HLB固相萃取小柱,用5 mL 10%甲醇溶液淋洗,6 mL甲醇洗脱。洗脱液于40℃氮吹至近干后,用甲醇定容至1 mL,过0.22μm有机滤膜,滤液在ACQIUTY UPLC BEH SHIELD RP18色谱柱上分离,以不同体积比的甲醇-水混合液为流动相进行梯度洗脱,质谱分析采用多反应监测采集模式,电喷雾正离子扫描模式,基质匹配法绘制工作曲线。结果表明,4种异噻唑啉酮类化合物的质量浓度在一定范围内与对应的峰面积呈线性关系,检出限(3S/N)分别为0.5,0.5,0.5,0.025...     

唾液中苯丙胺类毒品的液相小体积萃取GC/MS-SIM检测

建立了一种便捷的唾液中4种毒品(苯丙胺(AM)、甲基苯丙胺(MAM)、3,4-(亚甲二氧基)苯丙胺(MDA)、3,4(亚甲二氧基)-甲基苯丙胺(MDMA))的液相小体积超声提取-气相色谱/质谱-选择离子检测分析方法并考察了小体积萃取溶剂和体积对萃取效果的影响.该方法用100μL环己烷对唾液中的毒品进行提取,直接抽取提取液用气相色谱/质谱-选择离子(GC/MS-SIM)检测,获得良好线性,相对标准偏差在15%内,准确性均在80%～120%之间,最小检测限可达0.1μg/mL.该方法灵敏、简便、快速,可用于缴获毒品及嫌疑吸毒者人体生物检材中苯丙胺类毒品的分析.     

1-[（6-烷（苄）氧基-3，4-亚甲二氧基）苯基]-2-（1H-1，2，4-三唑）-乙酮（醇）类化合物的合成及抑菌活性

以3,4-亚甲二氧基苯酚和1-H-1,2,4-三唑为主要原料,合成了12种1-[(6-烷(苄)氧基-3,4-亚甲二氧基)苯基]-2-(1H-1,2,4-三唑)-乙酮(醇)类化合物.化合物经IR、1H NMR、13C NMR、元素分析测试技术进行了表征确证.初步牛物测试结果表明,在质量浓度为1×10-4g/mL下,化合物Vc对小麦赤霉病菌的抑制率达81.3%;化合物Ⅳe对马铃薯干腐病菌的抑制率达83.4%;化合物Ve、Vf对玉米弯孢病菌的抑制率分别达79.7%和72.4%.     

动态液相微萃取GC/MS-SIM方法检验毛发中的苯丙胺类毒品

建立了动态液相微萃取GC/MS-SIM方法检测毛发中4种苯丙胺类毒品的方法.毛发样品首先用1 mol/L NaOH溶液消解,然后用50μL氯仿涡旋提取1min,离心后用注射器直接抽取有机相,提取液进行GC/MS-SIM方法检测.毛发样品的测出限(S/N=3)分别为苯丙胺1 ng/mg,甲基苯丙胺、3、4-(亚甲二氧基)苯丙胺、3、4(亚甲二氧基)-甲基苯丙胺500 pg/mg.在毛发中添加上述4种苯丙胺毒品的质量分数为5 ng/mg时,5次测定的RSD分别为苯丙胺8.3%,甲基苯丙胺8.2%,3、4-(亚甲二氧基)苯丙胺2.0%,3、4(亚甲二氧基)2.7%.该方法可用于毛发中低含量苯丙胺类毒品的分析.     

快速溶剂萃取-气相色谱/质谱法分析血液中的甲卡西酮

建立血液中甲卡西酮快速溶剂萃取（ASE）-气相色谱/质谱（GC/ MS）分析的新方法. 通过优化 ASE 的萃取条件（溶剂、温度及时间）,对血液中的甲卡西酮进行有效提取,之后用 GC/ MS 进行定性、定量分析. 方法检出限为0. 02 mg / L,定量限为0. 1 mg / L. 血液中甲卡西酮在0. 5、1. 0 和2. 0 mg / L 3 个添加水平的平均回收率在96. 70% ~99. 27%之间,甲卡西酮在0. 1 ~ 50 mg / L 的浓度范围内线性良好. 方法快速、简便、高效且操作自动化,适用于血液中甲卡西酮的检验鉴定.     

Characterization of major degradation products of an adenosine A2A receptor antagonist under stressed conditions by LC‐MS and FT tandem MS analysis

Parkinson's disease (PD) is a very serious neurological disorder, and current methods of treatment fail to achieve long‐term control. SCH 420814 is a potent, selective and orally active adenosine A_2A receptor antagonist discovered by Schering‐Plough. Stability testing provides evidence of the quality of a bulk drug when exposed to the influence of environmental factors. Understanding the drug degradation profiles is critical to the safety and potency assessment of the drug candidate for clinical trials. As a result, identification of degradation products has taken an important role in drug development process. In this study, a rapid and sensitive method was developed for the structural determination of the degradation products of SCH 420814 formed under different forced conditions. The study utilizes a combination of liquid chromatography–tandem‐mass spectrometry (LC‐MS/MS) and Fourier Transform (FT) MS techniques to obtain complementary information for structure elucidation of the unknowns. This combination approach has significant impact on degradation product identification. A total of ten degradation products of SCH 420814 were characterized using the developed method. Copyright © 2009 John Wiley & Sons, Ltd.     

LC-ESI MS/MS测定蜜胺餐具中三聚氰胺的迁移量

建立了液相色谱串联电喷雾正离子源质谱(LC-ESI MS/MS)检测蜜胺餐具中三聚氰胺迁移量的方法.采用强阳离子交换柱,流动相为乙腈-10 mmol/L乙酸铵/乙酸缓冲溶液(pH 4.0)(40:60,体积比),以多反应离子监测对三聚氰胺做定性定量分析.在水、3%乙酸、10%乙醇模拟物中,三聚氰胺在3.00～130.0...     

乳腺癌代谢物组模式特征发现方法及HPLC/M S/M S分析

提出一种基于单独最优特征组合和BP神经网络的代谢物组模式特征发现方法,并用其寻找到尿样中与乳腺癌最为相关的4种核苷,组成一组特异性检测参数.经HPLC/MS/MS联用法鉴定,它们是乳清酸核苷、1-甲酰化腺苷、S-腺苷-L-蛋氨酸及N²-甲酰化鸟苷.将这4种核苷作为输入变量,用BP神经分类网络建立乳腺癌诊断模型.留一法交叉验证和独立验证结果表明,该模型预测准确率达到90%以上.     

Basic drug analysis by strong cation-exchange liquid chromatography-tandem mass spectrometry: simultaneous analysis of amisulpride, and of metamfetamine and amfetamine in serum/plasma

In the HPLC of basic drugs and metabolites, good efficiency and peak shape can often be attained using strong cation‐exchange packings with isocratic 100% methanol eluents containing an ionic modifier at an appropriate pH* and ionic strength. Solvent extracts can be analysed directly, and use of ammonium acetate as modifier facilitates the use of atmospheric pressure chemical ionization (APCI)–tandem mass spectrometry, selected reaction monitoring mode. For the analysis of amisulpride and of metamfetamine/amfetamine in plasma (200 µL) after single oral doses in man, a column packed with Waters Spherisorb S5SCX (5 µm average particle size, 100 × 2.1 mm i.d.) was used with methanolic ammonium acetate (40 mmol/L, pH* 6.0, flow rate 0.5 mL/min) as eluent (35°C). Deuterated internal standards were used for each analyte. Detection was by positive‐mode APCI. Responses for all analytes were linear over the calibration ranges. Intra‐assay precision (RSD) was 2–18%, and inter‐assay precision was 2–12%. The limit of detection was 0.5 µg/L for all analytes. No significant matrix effects or isobaric interferences were noted. The total analysis time was 7 min. Similar methodology can be applied to a wide range of basic analytes using MS/MS detection. Copyright © 2010 John Wiley & Sons, Ltd.     

LC/MS/MS for identification of in vivo and in vitro metabolites of jatrorrhizine

The in vivo and in vitro metabolism of jatrorrhizine has been investigated using a specific and sensitive LC/MS/MS method. In vivo samples including rat feces, urine and plasma collected separately after dosing healthy rats with jatrorrhizine (34 mg/kg) orally, along with in vitro samples prepared by incubating jatrorrhizine with rat intestinal flora and liver microsome, respectively, were purified using a C(18) solid-phase extraction cartridge. The purified samples were then separated with a reversed-phase C(18) column with methanol-formic acid aqueous solution (70:30, v/v, pH3.5) as mobile phase and detected by on-line MS/MS. The structural elucidation of the metabolites was performed by comparing their molecular weights and product ions with those of the parent drug. As a result, seven new metabolites were found in rat urine, 13 metabolites were detected in rat feces, 11 metabolites were detected in rat plasma, 17 metabolites were identified in intestinal flora incubation solution and nine metabolites were detected in liver microsome incubation solution. The main biotransformation reactions of jatrorrhizine were the hydroxylation reaction, the methylation reaction, the demethylation reaction and the dehydrogenation reaction of parent drug and its relative metabolites. All the results were reported for the first time, except for some of the metabolites in rat urine.     

Tandem mass spectrometry of synthetic polymers

The detailed characterization of macromolecules plays an important role for synthetic chemists to define and specify the structure and properties of the successfully synthesized polymers. The search for new characterization techniques for polymers is essential for the continuation of the development of improved synthesis methods. The application of tandem mass spectrometry for the detailed characterization of synthetic polymers using the soft ionization techniques matrix‐assisted laser desorption/ionization mass spectrometry (MALDI‐MS) and electrospray ionization mass spectrometry (ESI‐MS), which became the basic tools in proteomics, has greatly been increased in recent years and is summarized in this perspective. Examples of a variety of homopolymers, such as poly(methyl methacrylate), poly(ethylene glycol), as well as copolymers, e.g. copolyesters, are given. The advanced mass spectrometric techniques described in this review will presumably become one of the basic tools in polymer chemistry in the near future. Copyright © 2009 John Wiley & Sons, Ltd.     

动物源性食品中吡喹酮残留量的LC-MS/MS测定

应用固相萃取液相色谱-串联质谱法(LC-MS/MS)技术建立了动物源性食品中吡喹酮药物残留的检测方法。用乙酸乙酯提取样品中的吡喹酮残留,提取液经碱性氧化铝小柱净化,LC-MS/MS测定,在10~40μg/kg范围内添加回收率为91%~111%,定量下限(LOQ)为10μg/kg。本文还讨论了吡喹酮残留物的提取条件、流动相对吡喹酮ESI离子化的影响,并借助准MS/MS/MS技术探讨了吡喹酮主要质谱碎片的产生机理。     

A Microcomputer Controlled Tandem Quadrupole Mass Spectrometer Using a Direct Liquid Introduction Probe for Screening Analysis

Abstract

The use of a direct liquid introduction probe with a short guard column as the method of sample introduction is explored. This technique is an alternative to the conventional direct probe method. The method is rapid, involatile compounds can be analyzed, and volatile compounds are not lost in the vacuum lock. Screening for trichlorophenol in urine, by observing the loss of [M-HCOCI]⁺, is used to test the technique. The advantages and disadvantages of split and splitless direct liquid introduction probes and column concentration are discussed. Detection limits in the low nanograms were observed, and samples may be analyzed every 30 seconds.     

用GC-MS、GC-MS-MS方法检测某些有机质成熟度参数的比较

Tm／Ts,C29甾烷ααα20S／(20S+20R)是判断原油成熟度的重要参数。所以能否准确地检测这些化合物就显得尤为关键和重要。以往我们通常采用GC-MS单极质谱来检测原油和烃原岩抽提物中饱和烃里的萜烷和甾烷成分。但利用GC-MS单极质谱分析得到的m／z191质量色谱图中,Tm、Ts往往与三环和四环萜烷同时共流出,以至有时导致假的Tm／Ts比值。利用GC-MS单极质谱分析得到的m／z217质量色谱图中规则甾烷分布受重排甾烷的影响,很难区分C29甾烷和4-甲基甾烷(即没有办法排除共流峰的干扰)。这是因为Tm、Ts和C29甾烷等生物标记化合物在特定的色谱柱中有     

尿样中神经性毒剂代谢产物的HPLC/Q-TOFMS/MS检测方法研究

建立了尿样中甲基膦酸单乙酯(EMPA)、甲基膦酸单异丙酯(IMPA)、甲基膦酸频哪基酯(PMPA)3种神经性毒剂代谢产物的HPLC/Q-TOFMS/MS检测方法。以StrataSi-1型固相萃取小柱对尿样中的3种神经性毒剂代谢产物进行分离,HPLC/Q-TOFESIMS/MS进行测定,内标法定量。该方法对EMPA、IMPA、PMPA的线性范围均为5～320μg/L,相关系数均不低于0.9974;EMPA、IMPA、PMPA的加标回收率分别为57%、98%、81%;检出限(S/N≥3)均为0.1μg/L,定量下限(S/N≥10)均为1μg/L。并将该方法应用于禁化武组织(OPCW)首次生物医学样品分析演练未知尿样的检测,结果满意。